Inhalation and topical steroid therapy and oral candidiasis: A brief overview

Arjuna N B Ellepola*, H. M H N Bandara, Hugh D. Smyth

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter in a book


Candida-induced infection in the oral cavity is by far the commonest human fungal infection, which manifests in a variety of clinical guises. The foremost reason for its high occurrence appears to be the wide array of predisposing factors, which facilitate the transformation of oral commensal Candida to a parasitic existence. One such predisposing factor is the prolonged usage and off-targeting of inhaled corticosteroids, where oral candidiasis is a common side effect of such therapy. Due to the antiinflammatory and immunosuppressive effects steroids are used in the management of bronchial asthma and oral mucosal diseases. In this chapter we briefly discuss the clinical and laboratory findings on the relationship between steroids inhalers, other topical steroids and oral candidiasis, possible mechanisms of pathogenicity following such exposure to steroids as well as the precautions that could be taken to minimize this oral side effect of steroid therapy.

Original languageEnglish
Title of host publicationCandidiasis: Epidemiology, Symptoms and Treatment Options
PublisherNova Science Publishers, Inc
Number of pages14
ISBN (Print)9781626188709
Publication statusPublished - 2013


Dive into the research topics of 'Inhalation and topical steroid therapy and oral candidiasis: A brief overview'. Together they form a unique fingerprint.

Cite this